Year: 2016
Type: article
Abstract: Meta-analysis is an increasingly important aspect of drug development as companies look to benchmark their own compounds with the competition. There is scope to carry out a wide range of analyses addressing key research questions from preclinical through to postregistration. This set of tutorials will take the reader through key model-based meta-analysis (MBMA) methods with this first installment providing a general introduction before concentrating on classical and Bayesian methods for landmark data.
DOI: 10.1002/psp4.12041
Authors: M Boucher, M Bennetts
Institution: Pfizer (United Kingdom)
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $4,140
Funder: Pfizer
OpenAlex ID: W2102181259
